Offer to raise up to $6 million extended; Company in material negotiations for commercialising its d...
Media Coverage
ALL
Proteomics International
PromarkerEso
PromarkerEndo
PromarkerD
Investor relations
Featured
ASX Announcement
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
The Perth-based outfit is seeking to raise $4m-$6m to further its three-pronged approach of diagnosi...
Proteomics seeks $6m to fund protein research.
Proteomics to raise $4 million to $6 million in its initial public offer at 20 cents a share, to lis...
Emerging life science company Proteomics International Laboratories Ltd (proposed ASX: PIQ) is pleas...
Learn more about our Promarker® tests
Discover our portfolio of prognostic and diagnostic blood tests, developed to predict disease risk earlier and improve patient outcomes.